Expression and promoter-alternation of osteoblastic insulin-like growth factors

成骨细胞胰岛素样生长因子的表达和启动子改变

基本信息

  • 批准号:
    06671854
  • 负责人:
  • 金额:
    $ 1.41万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

Using a chondrocytic cell line HCS-2/8 derived from human chondrosarcoma, the quantitative analytical method adapting the RNase protection Assay (RPA) was developped in order to examine the expression and promoter-alternation of insulin-like growth factor genes. The probe of the RPA experiments was constructed for the promoters 2P-1,2P-3 and 2P-4 of IGF-2 and the promoters 1P-1 and 1P-2 of IGF-1, but the promoter 2P-2 of IGF-2 failed to be constructed because the transcriptional product was very little in HCS-2/8. Now, we continue to investigate the determination of detectable limitation of the RPA method using their probes, and we will retry to construct the probe asfter the accumulation of RT-PCR product for 2P-2 transcript.During the present developmental investigations, we found some new facts as following :1.The simultaneous expression of four promoters of IGF-2 were induced in HCS-2/8 and human normal chondrocytes.2.A defect of four base pair in the promoter 2P-4 transcript of IGF-2 in HCS-2/8 was observed at the 3'-end of exon 6, at which the position is upstream of 9 to 6 base from the translation-starting point. This defect may be due to the alternative splicing specific to the chondrosarcoma.3.Comparing with HCS-2/8 and human normal chondrocytes, we found a parallel correlation between IGF-2 and H19 (tumor reppressor gene) expressions.4.The restriction fragment length polymorphism of IGF-2 gene in HCS-2/8 suggested that only the paternal allele (s) existed at the genomic level, but the maternal imprinting allele was absent in the chondrosarcoma. This perhaps correlate with the tumor formation.
以人软骨肉瘤细胞系HCS-2/8为材料,建立了一种定量分析胰岛素样生长因子基因表达和启动子改变的RNA酶保护试验(RPA)方法。针对IGF-2的启动子2 P-1、2 P-3和2 P-4以及IGF-1的启动子1 P-1和1 P-2构建了RPA实验的探针,但IGF-2的启动子2 P-2由于在HCS-2/8中转录产物很少而未能构建。目前,我们继续研究使用它们的探针确定RPA方法的检测限,并将在2 P-2转录本的RT-PCR产物积累后尝试构建探针。1.在HCS-2/8和人正常软骨细胞中同时诱导了IGF-2的4个启动子的表达; 2.在HCS-2/8中观察到IGF-2的启动子2 P-4转录本在外显子6的3 '端存在4个碱基对的缺陷,在该位置处,该位置是从分离起始点开始的9至6个碱基的上游。通过与HCS-2/8和正常人软骨细胞的比较,发现IGF-2和H19之间存在平行相关性4. IGF-2基因在HCS-2/8中的限制性片段长度多态性表明,在基因组水平上仅存在父本等位基因,但软骨肉瘤中不存在母亲印记等位基因。这可能与肿瘤的形成有关。

项目成果

期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
高橋浩二郎,滝川正春: "軟骨と成長の制御-IGFsを中心に" CLINICAL CALCIUM. 42(5). 593-596 (1995)
Kojiro Takahashi、Masaharu Takikawa:“软骨和生长的控制 - 关注 IGF”《临床钙》42(5) (1995)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
高橋浩二郎: "軟骨と成長の制御-IGF_Sを中心に" CLINICAL CALCIUM. 45(5)(印刷中). (1995)
Kojiro Takahashi:“软骨和生长的控制 - 关注 IGF_S”《临床钙》45(5)(出版中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kojiro Takahashi: "Allelic excess-expression of IGF-ll transcripts and repressive expression in H19 gene in the human chondrosarcoma-derived chondrocytic cell lines, HCS-2/8 and HCS-2/A" (in preparing).
Kojiro Takahashi:“人软骨肉瘤来源的软骨细胞系 HCS-2/8 和 HCS-2/A 中 IGF-II 转录物的等位基因过度表达和 H19 基因的抑制表达”(准备中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kojiro Takahashi: "Specific defect of four base pairs at the 3-end of exon 6 in promoter-4 transcript of IGF-ll gene in the human chondrosarcoma-derived chon-drocytic cell line, HCS-2/8" (in preparing).
Kojiro Takahashi:“人软骨肉瘤来源的软骨细胞系 HCS-2/8 中 IGF-II 基因启动子 4 转录本中外显子 6 3 端的四个碱基对的特异性缺陷”(准备中)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kojiro Takahashi: "Specific defect of four base pairs at the 3'-end of exon 6 in promoter-4 transcript of IGF-II gene in the human chondrosarcoma-derived chondrocytic cell line, HCS-2/8" (in preparing).
Kojiro Takahashi:“人软骨肉瘤来源的软骨细胞系 HCS-2/8 中 IGF-II 基因启动子 4 转录物中外显子 6 3端 4 个碱基对的特异性缺陷”(正在准备中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKAHASHI Kojiro其他文献

TAKAHASHI Kojiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKAHASHI Kojiro', 18)}}的其他基金

Search for agonists of new plasma membrane estrogen receptors and their anti-stress effects
寻找新型质膜雌激素受体激动剂及其抗应激作用
  • 批准号:
    23590159
  • 财政年份:
    2011
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of chemical compounds derived from plants on the functions of catecholaminergic neurons and life span
植物化合物对儿茶酚胺能神经元功能和寿命的影响
  • 批准号:
    20590129
  • 财政年份:
    2008
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of environmental estrogenic pollutants on cellular functions in the noradrenergic neurons and search for their receptors
环境雌激素污染物对去甲肾上腺素能神经元细胞功能的影响及其受体的寻找
  • 批准号:
    17590111
  • 财政年份:
    2005
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of IGF-2 gene expression in human chondrosarcoma derived cell lines : HCS-2/8 and -2/A
人软骨肉瘤衍生细胞系中 IGF-2 基因表达的调节:HCS-2/8 和 -2/A
  • 批准号:
    08672124
  • 财政年份:
    1996
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on the alteration of calcium ions in osteoblastic cell line using a fluorescence dye
荧光染料对成骨细胞系钙离子变化的研究
  • 批准号:
    01571018
  • 财政年份:
    1989
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Regulation of alkaline phosphatase and the relation with calcification in hard tissues.
碱性磷酸酶的调节及其与硬组织钙化的关系。
  • 批准号:
    60570873
  • 财政年份:
    1985
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Role of insulin like growth factor-I on tooth morphogenesis
胰岛素样生长因子-I 对牙齿形态发生的作用
  • 批准号:
    24890026
  • 财政年份:
    2012
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Effect of insulin-like growth factor-I in intrauterine growth-restricted preterm infants.
胰岛素样生长因子-I 对宫内生长受限早产儿的影响。
  • 批准号:
    24591611
  • 财政年份:
    2012
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Drugs improve mouse cognitive function by increasing the production of insulin-like growth factor-I
药物通过增加胰岛素样生长因子-I 的产生来改善小鼠认知功能
  • 批准号:
    21791771
  • 财政年份:
    2009
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Regulation of insulin-like growth factor I receptor tyrosine kinase
胰岛素样生长因子I受体酪氨酸激酶的调节
  • 批准号:
    7578946
  • 财政年份:
    2008
  • 资助金额:
    $ 1.41万
  • 项目类别:
Regulation of insulin-like growth factor I receptor tyrosine kinase
胰岛素样生长因子I受体酪氨酸激酶的调节
  • 批准号:
    7364070
  • 财政年份:
    2008
  • 资助金额:
    $ 1.41万
  • 项目类别:
Regulation of insulin-like growth factor I receptor tyrosine kinase
胰岛素样生长因子I受体酪氨酸激酶的调节
  • 批准号:
    7752492
  • 财政年份:
    2008
  • 资助金额:
    $ 1.41万
  • 项目类别:
Regulation of insulin-like growth factor I receptor tyrosine kinase
胰岛素样生长因子I受体酪氨酸激酶的调节
  • 批准号:
    7995988
  • 财政年份:
    2008
  • 资助金额:
    $ 1.41万
  • 项目类别:
Effect of Insulin-like Growth Factor I on Ischemia-Reperfusion Injury in Diabetic Heart
胰岛素样生长因子I对糖尿病心脏缺血再灌注损伤的影响
  • 批准号:
    19590831
  • 财政年份:
    2007
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Innovative Approaches for Defining the Interaction of Insulin like Growth Factor I (IGF I) with the Type 1 IGF Receptor
定义胰岛素样生长因子 I (IGF I) 与 1 型 IGF 受体相互作用的创新方法
  • 批准号:
    DP0664311
  • 财政年份:
    2006
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Discovery Projects
Insulin-like growth factor-I receptor-targeted cancer therapy
胰岛素样生长因子-I 受体靶向癌症治疗
  • 批准号:
    17570120
  • 财政年份:
    2005
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了